I find it interesting that the vast majority of posts on this forum discuss the this and that of whatever, with the underlying assumption that we are heading for an SP of $50 to (wait for it) $1000.
Whilst the lower end of that is distinctly possible, I don't countenance any of it as yet. There is risk to be bridged still ahead. The nearest term risk is Acadia's upcoming earnings call, but more importantly, the actual earnings growth over the next year or so, then beyond.
Following the earnings call, the more critical 2591 PMD result comes into play and then over the course of next year the 3 other trial results.
So for me, one stepping stone at a time must be ticked before moving on to the next. I realise the reward/risk situation is very positive, but certainly not a foregone conclusion. No $50+ dreams for me until a few more risks have been ticked off.
- Forums
- ASX - By Stock
- NEU
- Share Price
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.55%
!
$20.14

Share Price, page-7399
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$20.14 |
Change
0.500(2.55%) |
Mkt cap ! $2.543B |
Open | High | Low | Value | Volume |
$19.72 | $20.55 | $19.65 | $20.21M | 996.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 400 | $20.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.28 | 1110 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400 | 20.120 |
4 | 5669 | 20.110 |
1 | 25 | 20.060 |
2 | 650 | 20.000 |
2 | 2272 | 19.800 |
Price($) | Vol. | No. |
---|---|---|
20.280 | 1110 | 2 |
20.300 | 1000 | 1 |
20.480 | 4000 | 1 |
20.500 | 1800 | 2 |
20.550 | 9819 | 3 |
Last trade - 16.16pm 18/09/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |